BRANDI JOYNER: Open Payments
NPI 1821769381 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,605 in 107 payments from 21 companies in 2025. Trend: 2023 $2,837 · 2024 $3,267 · 2025 $2,605
Food & beverage: $2,605
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 18 | $545 |
| AstraZeneca Pharmaceuticals LP | 14 | $351 |
| Novo Nordisk Inc | 13 | $251 |
| Lilly USA, LLC | 7 | $207 |
| Sumitomo Pharma America, Inc. | 9 | $200 |
| Amgen Inc. | 7 | $197 |
| ABBVIE INC. | 12 | $163 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Edwards Lifesciences Corporation | 1 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $93 |
Products named: Kerendia, GEMTESA, FARXIGA, EVENITY, Symbravo, KISUNLA, Rybelsus, Ozempic.
Industry payments across TX — which companies pay providers there.
